| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Department of Immunology and The Barbara Davis Center for Childhood Diabetes, University of Colorado Health Sciences Center, Denver, CO 80262
It has been widely assumed that T cells from TCR-transgenic (Tg) mice better represent the behavior of T cells from normal mice than do in vitro cultures of T cell clones. We have found that autoreactive T cells arising in the presumably more physiological environment of the BDC-2.5 TCR-Tg mouse, despite being apparently "naive" in surface phenotype, are highly activated functionally and do not resemble CD4+ T cells from a spontaneously diabetic nonobese diabetic (NOD) mouse or the NOD-derived, diabetogenic CD4+ T cell clone of origin, BDC-2.5. Our results suggest that autoreactive T cells cloned from the spontaneously diabetic NOD mouse more closely resemble effector T cells arising during the natural disease process.
This article has been cited by other articles:
|
|
 |
|
  A. Suri, J. J. Walters, H. W. Rohrs, M. L. Gross, and E. R. Unanue First Signature of Islet {beta}-Cell-Derived Naturally Processed Peptides Selected by Diabetogenic Class II MHC Molecules J. Immunol., March 15, 2008; 180(6): 3849 - 3856. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. E. Weber, J. Harbertson, E. Godebu, G. A. Mros, R. C. Padrick, B. D. Carson, S. F. Ziegler, and L. M. Bradley Adaptive islet-specific regulatory CD4 T cells control autoimmune diabetes and mediate the disappearance of pathogenic Th1 cells in vivo. J. Immunol., April 15, 2006; 176(8): 4730 - 4739. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. E. Pauza, C. M. Dobbs, J. He, T. Patterson, S. Wagner, B. S. Anobile, B. J. Bradley, D. Lo, and K. Haskins T-Cell Receptor Transgenic Response to an Endogenous Polymorphic Autoantigen Determines Susceptibility to Diabetes Diabetes, April 1, 2004; 53(4): 978 - 988. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. You, C. Chen, W.-H. Lee, C.-H. Wu, V. Judkowski, C. Pinilla, D. B. Wilson, and C.-P. Liu Detection and Characterization of T Cells Specific for BDC2.5 T Cell-Stimulating Peptides J. Immunol., April 15, 2003; 170(8): 4011 - 4020. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Yoshida, T. Martin, K. Yamamoto, C. Dobbs, C. Munz, N. Kamikawaji, N. Nakano, H.-G. Rammensee, T. Sasazuki, K. Haskins, et al. Evidence for shared recognition of a peptide ligand by a diverse panel of non-obese diabetic mice-derived, islet-specific, diabetogenic T cell clones Int. Immunol., December 1, 2002; 14(12): 1439 - 1447. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. H. Friedline, C. P. Wong, D. A. Steeber, T. F. Tedder, and R. Tisch L-Selectin Is Not Required for T Cell-Mediated Autoimmune Diabetes J. Immunol., March 15, 2002; 168(6): 2659 - 2666. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. D. Piganelli, S. C. Flores, C. Cruz, J. Koepp, I. Batinic-Haberle, J. Crapo, B. Day, R. Kachadourian, R. Young, B. Bradley, et al. A Metalloporphyrin-Based Superoxide Dismutase Mimic Inhibits Adoptive Transfer of Autoimmune Diabetes by a Diabetogenic T-Cell Clone Diabetes, February 1, 2002; 51(2): 347 - 355. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
